ICH Project ICH S6(R1) Guideline Workshops ICH S6(R1) Guideline Workshops on Non-clinical Safety Assessment of Biopharmaceuticals

August 08, 2011

ICH S6(R1) "Non-clinical Safety Evaluation of Biotechnology-based Medicinal Products" has now been harmonized by Japan, the U.S., and the EU, and a Guideline Workshops were held on the following dates. Approximately 100 participants from not only JPMA member companies but also from a wide range of related companies attended the meeting, where a lively question-and-answer session was held.

The following is a list of the presentation materials used at the briefing.
Unauthorized copying or reproduction of any of the materials is strictly prohibited.

Date, Time, and Location

Date and time Place

Friday, September 5, 2011, 13:30-16:00

Japan Pharmaceutical Manufacturers Association
2-3-11 Nihonbashi-Honcho, Chuo-ku, Tokyo

Information and Program

Information (151KB)

Briefing Materials

Presentations Speakers

1 ICH S6(R1) Background and Future Expectations (1,635KB)

Japan Pharmaceutical Manufacturers Association
ICH Project S6 (R1) Topic Leader
Kazuto Watanabe

2 ICH S6 (R1) contents and points to note (1,835 KB)

Pharmaceuticals and Medical Devices Agency
Kazushige Maki

For inquiries, please contact

JPMA ICH Secretariat

Phone
03-3241-0326
 

Share this page

TOP